QuidelOrtho Corp (QDEL) Insider Purchases 15,021 Shares
Insider Ann D. Rhoads bought 15,021 shares of QuidelOrtho Corp.
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for QuidelOrtho Corp.
Last Updated: Nov 8, 2025, 3:46 PM · Source: Finnhub.io
Insider Ann D. Rhoads bought 15,021 shares of QuidelOrtho Corp.
Citigroup has downgraded QuidelOrtho Corp (QDEL) to Neutral from Buy.
QuidelOrtho Corp (QDEL) posts Q3 2025 EPS of $0.80, beating estimates.